Learning Objectives:

  • Understand the role of TET2 in blood cell development
  • How mutations in TET2 impact blood caners and benign disorders
  • How we can leverage epigenetic drugs to treat diseases that are impacted by TET2 mutations
Session date: 
06/26/2023 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Amittha Wickrema, PhD